Retinal Degenerative Diseases - Laboratory and Therapeutic Investigations

von: Robert E. Anderson, Joe G. Hollyfield, Matthew M LaVail

Springer-Verlag, 2010

ISBN: 9781441913999 , 808 Seiten

2. Auflage

Format: PDF, OL

Kopierschutz: Wasserzeichen

Windows PC,Mac OSX für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Online-Lesen für: Windows PC,Mac OSX,Linux

Preis: 341,33 EUR

Mehr zum Inhalt

Retinal Degenerative Diseases - Laboratory and Therapeutic Investigations


 

Dedication

6

Preface

10

Contents

14

Contributors

24

Travel Awards

44

About the Editors

46

Part I Basic Science Underlying Retinal Degeneration

49

1 Analysis of Genes Differentially Expressed During Retinal Degeneration in Three Mouse Models

50

1.1 Introduction

50

1.2 Methods

51

1.2.1 RNA Preparation and cDNA Labeling

51

1.2.2 Hybridization of Slides, Image Acquisition and Bioinformatics

51

1.2.3 Real-Time PCR

51

1.3 Results

51

1.3.1 Microarray Analysis of Opsin 02550256 0/0 Model

52

1.3.2 Microarray Analysis of Bouse C Model

54

1.3.3 Microarray Analysis of MOT1 Mouse

57

1.4 Discussion

59

References

59

2 Regulation of Angiogenesis by Macrophages

61

2.1 Macrophage Polarization and Its Role in Angiogenesis

63

References

64

3 Protein Kinase C Regulates Rod Photoreceptor Differentiation Through Modulation of STAT3 Signaling

66

3.1 Introduction

66

3.2 Materials and Methods

67

3.2.1 Reagents

67

3.2.2 Animals and Retina Explant Culture

68

3.2.3 Cell Culture

68

3.2.4 Western Blot Assay

68

3.3 Results

69

3.3.1 Phorbol Esters Increase Rod Generation

69

3.3.2 Expression of PKC Isoforms in Developing Retina

70

3.3.3 Activation of PKC Decreases Phosphorylation of STAT3

70

3.4 Discussion

70

References

72

4 Pigment Epithelium-derived Factor Receptor (PEDF-R): A Plasma Membrane-linked Phospholipase with PEDF Binding Affinity

74

4.1 Introduction

74

4.2 Identification of a PEDF Receptor

75

4.3 In Silico Information

75

4.4 Expression and Distribution in the Retina

76

4.5 Transmembrane Topology

78

4.6 Binding to PEDF Ligands

78

4.7 Phospholipase Activity

78

4.8 PEDF-R Activity in Retinal Cells

79

4.9 Conclusions

79

References

81

5 The Function of Oligomerization-Incompetent RDS in Rods

83

References

89

6 The Association Between Telomere Length and Sensitivity to Apoptosis of HUVEC

91

6.1 Introduction

91

6.2 Methods

92

6.2.1 The Culture of HUVEC and the Construction of Cell Division Model

92

6.2.2 Construction of an Apoptosis Model of HUVEC with Free Hydroxyl Radicals

92

6.2.3 Measurement of Apoptosis Rates and Telomere Lengths

93

6.2.4 Statistics Analysis

93

6.3 Results

93

6.3.1 Relationship Between the Time of Culture and the Telomere Length

93

6.3.2 Relationship Among Apoptosis Rates, Culture Times and Oxidation

93

6.3.3 Oxidation Enhances the Telomere Shortening

94

6.4 Discussion

95

References

96

7 Photoreceptor Guanylate Cyclases and cGMP Phosphodiesterases in Zebrafish

98

7.1 Regulation of cGMP Levels in Photoreceptor Outer Segments

98

7.2 Retinal Disorders Associated with Mutations in RetGCs and PDE6

99

7.3 Analysis of Teleost RetGC and PDEs in Retinal Function and Disorders

100

References

103

8 RDS in Cones Does Not Interact with the Beta Subunit of the Cyclic Nucleotide Gated Channel

105

References

111

9 Increased Expression of TGF-1 and Smad 4 on Oxygen-Induced Retinopathy in Neonatal Mice

113

9.1 Introduction

113

9.2 Material and Methods

114

9.2.1 Animals

114

9.2.2 Methods

114

9.2.2.1 TGF- Immunohistochemistry (IH) and Smad-4 In Situ Hybridization (ISH)

114

9.2.3 Statistical Analysis

114

9.3 Results

115

9.4 Discussion

117

References

118

10 ZBED4, A Novel Retinal Protein Expressed in Cones and Mller Cells

120

10.1 Introduction

120

10.2 Methods and Results

121

10.2.1 ZBED4 mRNA is Expressed in Human Retina

121

10.2.2 ZBED4 mRNA is Expressed in Mouse and Human Cones

121

10.2.3 ZBED4 is Expressed Both in Nuclei and Cytoplasm of Human Cones

124

10.2.3.1 Human ZBED4 is Also Expressed in Müller Cells Endfeet

124

10.2.4 Human ZBED4 is Distributed Between Nuclear and Cytoplasmic Retinal Fractions

124

10.2.5 Subcellular Localization of ZBED4 in Stably Transfected Cells

124

10.2.6 Purification of His-Tagged ZBED4 and Its Dimerization In Vivo

126

10.2.7 Mass Spectrometry Identifies Putative Proteins Interacting with ZBED4

126

10.3 Discussion

127

References

128

11 Tubby-Like Protein 1 (Tulp1) Is Required for Normal Photoreceptor Synaptic Development

129

11.1 Introduction

129

11.2 Methods

130

11.2.1 Animals

130

11.2.2 Immunofluorescent Staining of Retinal Sections

131

11.3 Results

131

11.4 Discussion

134

References

135

12 Growth-Associated Protein43 (GAP43) Is a Biochemical Marker for the Whole Period of Fish Optic Nerve Regeneration

137

12.1 Introduction

137

12.2 Experimental Procedures

138

12.2.1 Animal

138

12.2.2 Immunohistochemistry

138

12.2.3 RT-PCR Analysis

139

12.2.4 Behavioral Analysis

139

12.3 Results

139

12.3.1 Immunohistochemical Studies of GAP43 Protein in the Goldfish Retina After Optic Nerve Transection

139

12.3.2 Time Course of GAP43 mRNA Expression in the Goldfish Retina During Optic Nerve Regeneration

139

12.3.3 Chasing Behavior of Two Goldfish with Treatment of Optic Nerve Transection During Optic Nerve Regeneration

141

12.4 Discussion

142

12.4.1 Termination of Optic Nerve Regeneration in Goldfish

142

12.4.2 GAP43 Is a Good Marker for Monitoring the Long Process of Optic Nerve Regeneration in Fish

142

References

144

13 Multiprotein Complexes of Retinitis Pigmentosa GTPase Regulator (RPGR), a Ciliary Protein Mutated in X-Linked Retinitis Pigmentosa (XLRP)

145

13.1 X-Linked RP (XLRP)

145

13.2 Retinitis Pigmentosa GTPase Regulator (RPGR)

146

13.3 RPGR Isoforms in the Retina

147

13.4 Animal Models of RPGR

147

13.5 Sensory Cilia

147

13.6 Retinal Degeneration Caused by Mutations in Ciliary Proteins

148

13.7 Macromolecular Complexes of RPGR ORF15

148

13.8 Dissection of RPGR ORF15 Complexes

149

13.9 Conclusion

150

References

151

14 Misfolded Proteins and Retinal Dystrophies

155

14.1 Endoplasmic Reticulum Stress and Retinal Degeneration

155

14.2 Misfolded Proteins in Photoreceptors

156

14.3 Misfolded Proteins in Retinal Pigment Epithelial Cells

158

14.4 Pharmacologic Targeting of Protein Misfolding to Prevent Retinal Degeneration

159

References

159

15 Neural Retina and MerTK-Independent Apical Polarity of v5 Integrin Receptors in the Retinal Pigment Epithelium

162

15.1 Introduction

163

15.2 Functions of Apical v5 Integrin Receptors in Retinal Phagocytosis and Adhesion

163

15.3 Apical Polarity of v5 Integrin Receptors is Independent of the Neural Retina

164

15.4 Apical Polarity of v5 Receptors is Independent of the Essential Engulfment Receptor MerTK

167

15.5 Motifs of the 5 Integrin Subunit Cytoplasmic Domain that May Promote Apical Polarity of v5 Integrin Receptors

168

15.6 Perspective

169

References

170

16 Mertk in Daily Retinal Phagocytosis: A History in the Making

171

16.1 Introduction

171

16.2 RCS Rat and MerTK Receptor: An Intimate Story

172

16.3 Changes Associated with Absence of MerTK in the Rat Retina

173

16.4 Daily Rhythmic Activation of Mertk: The Intracellular Way

174

16.5 The Debate About MerTK Ligands In Vivo

175

16.6 Perspectives

176

References

176

17 The Interphotoreceptor Retinoid Binding (IRBP)Is Essential for Normal Retinoid Processing in ConePhotoreceptors

179

17.1 Introduction

179

17.2 The Cone Population in Irbp/Mice

181

17.3 Implications for IRBP and Cone Function

184

17.4 The Cone Visual Cycle

184

References

186

18 Aseptic Injury to Epithelial Cells Alters Cell Surface Complement Regulation in a Tissue Specific Fashion

188

18.1 Introduction

188

18.2 Material and Methods

189

18.2.1 Reagents

189

18.2.2 Cell Culture

190

18.2.3 Flow Cytometry

190

18.3 Results

191

18.3.1 Oxidative Stress, but Not Chemical Hypoxia, Alters the Expression of Complement Regulatory Proteins on ARPE-19 Cells

191

18.3.2 Oxidative Stress of Renal Tubular Epithelial Cells Does Not Alter Surface Expression of Crry by the Cells

192

18.3.3 Expression of MCP, CD55 and CD59 on the Surface of Lung Epithelial Cells Increases After Oxidative Stress, but This Does Not Prevent Complement-Activation on the Cell Surface

192

18.4 Discussion

192

References

195

19 Role of Metalloproteases in Retinal Degeneration Induced by Violet and Blue Light

196

19.1 Introduction

197

19.2 Objective

198

19.3 Materials and Methods

198

19.4 Results

199

19.5 Conclusion

200

References

200

20 Mitochondrial Decay and Impairment of Antioxidant Defenses in Aging RPE Cells

202

20.1 Summary

202

20.2 Introduction

203

20.3 Materials and Methods

204

20.3.1 Primary Human RPE Cell Culture

204

20.3.2 Hydrogen Peroxide Toxicity -- PI Assays

204

20.3.3 Mitochondrial Morphometrics

204

20.3.4 Protein and Weight Estimation of RPE Cells and Mitochondria

205

20.3.5 Measurement of ROS, ATP and Mitochondrial Membrane Potential (00 m )

205

20.3.6 Measurement of ([Ca2+]c) and ([Ca2+ ]m)

206

20.3.7 Expression of Mitochondrial Associated Genes

206

20.4 Results

206

20.4.1 Age Related Sensitivity of RPE Cells to Oxidative Stress

206

20.4.2 Variation in Mitochondrial Number, Structure, and Size

207

20.4.3 ROS and ATP Production, and 00 m Decrease in RPE Cells with Aging

209

20.4.4 Age-Related Variations in ([Ca2+]c) and ([Ca 2+] m ) in RPE Cells

211

20.4.5 Expression of Genes Associated with Mitochondrial Function

212

20.5 Discussion

214

References

217

21 Ciliary Transport of Opsin

221

21.1 Introduction

221

21.2 Methods

222

21.3 Results

223

21.4 Discussion

223

References

226

22 Effect of Hesperidin on Expression of Inducible Nitric Oxide Synthase in Cultured Rabbit Retinal Pigment Epithelial Cells

228

22.1 Introduction

229

22.2 Materials and Methods

230

22.2.1 Preparing Hesperidin Extract of Pericarpium Citri Reticulatae

230

22.2.2 Identification of Hesperidin by High Performance Liquid Chromatogram (HPLC)

231

22.2.3 Cell Culture

231

22.2.4 MTT Cell Viability Assay

232

22.2.5 Assay of NO Production

232

22.2.6 Cellular Immunohistochemistry of iNOS

232

22.2.7 Statistical Analysis

233

22.3 Results

233

22.3.1 Identification of Hesperidin by HPLC

233

22.3.2 RPE Cells Morphology

233

22.3.3 Influence of Hesperin on RPE Cell Proliferation Under the Condition of High Glucose

233

22.3.4 Assay of NO and iNOS

233

22.4 Discussion

234

References

235

23 Profiling MicroRNAs Differentially Expressed in Rabbit Retina

237

23.1 Introduction

237

23.2 Materials and Methods

238

23.2.1 Rabbit Retina Tissues

238

23.2.2 RNA Extraction

239

23.2.3 miRNA Microarray Analysis

239

23.2.4 Data Analysis

239

23.2.5 Bioinformatics Analysis of the Selected Mirnas

239

23.3 Results and Discussion

240

23.3.1 miRNA Microarray Analysis

240

23.3.2 Putative miRNA Target Gene Prediction

241

References

242

24 Unexpected Transcriptional Activity of the Human VMD2 Promoter in Retinal Development

244

24.1 Introduction

244

24.2 Materials and Methods

245

24.2.1 Experiment with Animals

245

24.2.2 -Galactosidase Assay

245

24.3 Results

245

24.3.1 Generation of Transgenic Mice

245

24.3.2 Localization of Cre Function in Transgenic Mice

246

24.4 Discussion

246

References

249

25 Microarray Analysis of Hyperoxia Stressed Mouse Retina: Differential Gene Expression in the Inferior and SuperiorRegion

250

25.1 Introduction

251

25.2 Methods

251

25.3 Result

252

25.4 Conclusions

255

References

255

26 Photoreceptor Sensory Cilia and Inherited Retinal Degeneration

256

26.1 PSC Proteins Involved in Inherited Retinal Degenerations

256

26.2 Structure of Photoreceptor Sensory Cilium Complex

257

26.3 Protein Components of Photoreceptor Sensory Cilium: PSC Proteome

258

26.4 Novel Photoreceptor Cilia Proteins in PSC Proteome

259

26.4.1 Subcellular Locations of Candidate Novel PSC Proteins

259

26.4.2 Functional Analysis of Novel PSC Proteins in Photoreceptor and Renal Cilia

260

26.4.2.1 shRNAs Against Novel PSC Genes

260

26.4.2.2 Evaluation of Phenotypes of shRNA Knockdown in mIMCD3 Cells and PSCs

260

26.5 TTC21B Protein in Photoreceptor Sensory Cilia and Renal Primary Cilia

261

26.5.1 TTC21B Localizes to the Basal Bodies and Transition Zone of Primary and Photoreceptor Sensory Cilia

261

26.5.2 TTC21B is Required for Primary Cilia and Photoreceptor Sensory Cilia Formation

262

26.6 Future Direction: Screening Novel PSC Genes for Mutations that Cause IRDs

263

References

263

27 Role of Elovl4 Protein in the Biosynthesisof Docosahexaenoic Acid

266

27.1 Introduction

266

27.2 Materials and Methods

267

27.2.1 RNA Interference

267

27.2.2 Construction of Mouse Anti Elovl4 Gene shRNA

267

27.2.3 Tissue Culture

268

27.2.4 Fatty Acid Analysis

268

27.3 Results

268

27.3.1 661W Cells Express Elovl4 and Can Elongate 18:3n3 and 22:5n3 to Longer Chain Fatty Acids

268

27.3.2 Knock-Down of Endogenous Elovl4 Does Not Affect C18--C24 PUFA Synthesis

269

27.4 Discussion

269

References

273

Part II Molecular Genetics and Candidate Genes

276

28 Molecular Pathogenesis of Achromatopsia Associated with Mutations in the Cone Cyclic Nucleotide-Gated Channel CNGA3 Subunit

277

28.1 Introduction

277

28.2 Materials and Methods

279

28.2.1 Constructs, Cell Culture and Transfection

279

28.2.2 Ratiometric Measurement of Intracellular Ca2+ Concentration

279

28.2.3 Electrophysiological Recordings

279

28.2.4 SDS-PAGE and Western Blot Analysis

280

28.2.5 Immunofluorescence Labeling and Confocal Microscopy

280

28.3 Results

280

28.3.1 The R218C and R224W Mutations Cause Loss of Channel Function

280

28.3.2 The R218C and R224W Mutations Cause Channel Mis-Localization

282

28.3.3 Co-Expression of The R218C and R224W Mutants with the Wild Type Channel Does Not Affect the Channel Activity

282

28.4 Discussion

283

References

284

29 Mutation Spectra in Autosomal Dominant and Recessive Retinitis Pigmentosa in Northern Sweden

286

29.1 Introduction

286

29.2 Materials and Methods

287

29.2.1 Patients and Ophthalmologic Examinations

287

29.2.2 Molecular Genetic Analysis

287

29.3 Results and Discussion

288

29.3.1 adRP

288

29.3.2 Bothnia Dystrophy

291

29.4 Conclusions

292

References

293

30 1 Rhodopsin Mutations in Congenital Night Blindness

294

30.1 Introduction

294

30.2 Properties of Rhodopsin CSNB Mutants

295

30.2.1 Spectral and Photochemical Properties

295

30.2.2 Retinal Binding Kinetics of Rhodopsin CSNB Mutants

296

30.2.3 Activity of CSNB Mutants

297

30.2.3.1 In Vitro Assays of CSNB Mutants

297

30.2.3.2 Electrophysiological Studies on Transgenic Animal Models

298

30.3 Proposed Mechanisms of CSNB Mutations

300

30.3.1 Desensitization Due to Mutant Opsin Activity in Xenopus

300

30.3.2 Proposed Dark-Active Rhodopsin in Mouse

301

30.4 Future Studies

302

References

302

31 GCAP1 Mutations Associated with Autosomal Dominant Cone Dystrophy

304

31.1 Heterogeneity of Autosomal Dominant Cone and Cone-Rod Dystrophies

305

31.2 Guanylate Cyclase 1 (GC1) and GCAP1

305

31.3 The EF Hand Motifs of GCAP1

308

31.4 GUCA1A Mutations Associated with adCD and adCRD

308

31.5 EF3: The GCAP1(Y99C) and GCAP1(N104K) Mutations

309

31.6 EF4: The GCAP1(I143NT), GCAP1(L151F) and GCAP1(E155G) Mutations

310

31.7 Conclusion

311

References

311

32 Genotypic Analysis of X-linked Retinoschisis in Western Australia

314

32.1 Introduction

314

32.2 Methodology

315

32.2.1 Molecular Genetic Studies

315

32.2.2 Electrophysiological Studies

316

32.3 Results

316

32.3.1 RS1 Mutations in Western Australian Families

316

32.3.2 Compromised Full-Field and mfERG in an Obligate Carrier with 52+1G 0 T Mutation

317

32.3.3 Likely Pathogenicity of the Novel 289TG Genetic Variant

317

32.3.3.1 Family Information

317

32.3.3.2 Patient Information

317

32.3.3.3 Genetic Information

317

32.4 Discussion

320

References

321

33 Mutation Frequency of IMPDH1 Gene of Han Population in Ganzhou City

323

33.1 Introduction

323

33.2 Materials and Methods

324

33.2.1 Subjects

324

33.2.2 DNA Extraction

325

33.2.3 Amplification of IMPDH1 Genes

325

33.2.4 RFLP Analysis

325

33.2.5 Statistical Analysis

325

33.3 Results

326

33.4 Discussion

326

References

327

Part III Diagnostic, Clinical, Cytopathological and Physiologic Aspects of Retinal Degeneration

328

34 Reversible and Size-Selective Opening of the Inner Blood-Retina Barrier: A Novel Therapeutic Strategy

329

34.1 Introduction

329

34.2 Materials and Methods

331

34.2.1 Animal Experiments and Experimental Groups

331

34.2.2 Web-Based siRNA Design Protocols Targeting Claudin-5

332

34.2.3 In Vivo Delivery of siRNA to Murine Retinal Capillary Endothelial Cells by Large Volume Hydrodynamic Injection

332

34.2.4 Indirect Immunostaining of Retinal Flatmounts

332

34.2.5 Assessment of BRB Integrity by Perfusion of Hoechst (H33342)

333

34.2.6 Magnetic Resonance Imaging (MRI)

333

34.3 Results

333

34.3.1 Claudin-5 Levels in Retinal Flatmounts

333

34.3.2 Perfusion of Hoechst 33342 (562 Da) in Mice Post-Delivery of Claudin-5 Sirna

333

34.3.3 MRI Analysis of Ibrb Integrity Following Rnai of Claudin-5

334

34.4 Discussion

334

References

336

35 Spectral Domain Optical Coherence Tomography and Adaptive Optics: Imaging Photoreceptor Layer Morphology to Interpret Preclinical Phenotypes

337

35.1 Introduction

337

35.2 Materials and Methods

338

35.2.1 Subjects

338

35.2.2 Adaptive Optics Retinal Imaging

339

35.2.3 Spectral Domain Optical Coherence Tomography

340

35.3 Results

341

35.3.1 Cone Photoreceptor Mosaic Topography

341

35.3.2 Outer Nuclear Layer Thickness

342

35.4 Discussion

343

References

343

36 Pharmacological Manipulation of Rhodopsin RetinitisPigmentosa

345

36.1 Introduction

345

36.2 Pharmacological Strategies for Misfolding Mutant Rod Opsin

346

36.2.1 Pharmacological Chaperones

346

36.2.2 Kosmotropes

347

36.2.3 Molecular Chaperone Inducers

348

36.2.4 Autophagy Inducers

349

36.3 Conclusion

349

References

350

37 Targeted High-Throughput DNA Sequencing for Gene Discovery in Retinitis Pigmentosa

352

37.1 Introduction

352

37.2 Methods

354

37.2.1 Selection of Families

354

37.2.2 VisionCHIP Gene Selection

354

37.2.3 VisionCHIP Validation

355

37.2.4 Evaluating Potentially Pathogenic Variants

356

37.3 Conclusion

357

References

358

38 Advances in Imaging of Stargardt Disease

359

38.1 Introduction

359

38.2 Fundus Autofluorescence

360

38.3 OCT

361

38.4 Adaptive Optics Scanning Laser Ophthalmoscope

361

38.5 Conclusion

364

References

365

39 Protamine Sulfate Downregulates Vascular Endothelial Growth Factor (VEGF) Expression and Inhibits VEGF and Its Receptor Binding in Vitro

367

39.1 Materials and Methods

368

39.1.1 Cell Culture

368

39.1.2 Semi-Quantitative Assay of VEGF Expression in the Culture Cells by ICC

368

39.1.3 VEGF Expression was Determined by ELISA

369

39.1.4 Statistical Analysis

369

39.2 Results

369

39.2.1 The Maximum Inhibition of VEGF Expression by Protamine Sulfate

369

39.2.2 Protamine Sulfate Inhibits the RF/6A Cell VEGF Expression at the Hypoxic Condition

369

39.2.3 Protamine Sulfate Inhibits the Binding of VEGF to Its Receptor

370

39.3 Discussions

371

39.3.1 The Inhibition Effect of Protamine Sulfate on VEGF

372

39.3.2 Inhibition of the Binding Between VEGF and Its Receptor

372

39.3.3 The Potential Use of Protamine Sulfate Inhibition of Angiogenic Eye Diseases

373

References

373

40 Computer-Assisted Semi-Quantitative Analysis of Mouse Choroidal Density

374

40.1 Introduction

374

40.2 Methods

375

40.2.1 Immunohistochemial Staining of Choroidal Endothelia

375

40.2.2 Analysis of Choriodal Density with Photoshop 8.0

375

40.3 Results and Discussion

376

40.3.1 Analysis Of Choroidal Density

376

40.3.2 Usefulness of the Methodology

377

40.3.3 Summary

377

References

378

41 Thioredoxins 1 and 2 Protect Retinal Ganglion Cells from Pharmacologically Induced Oxidative Stress, Optic Nerve Transection and Ocular Hypertension

379

41.1 Introduction

379

41.2 Methods

380

41.2.1 Animals

380

41.2.2 RGC Counting

381

41.2.3 RGC Isolation

381

41.2.4 Western Blot Analysis

381

41.2.5 RGC-5 Culture and Transfection

381

41.2.6 Cell Viability Assay

382

41.2.7 In Vivo Electroporation (ELP)

382

41.2.8 Statistical Analysis

382

41.3 Results

382

41.3.1 Expression of TRX1, TRX2 and TXNIP in the Retina After ONT and IOP Elevation and in RGC-5 Cells with Induced Oxidative Stress

382

41.3.1.1 TRX Expression in RGC-5 Cells in Response to Oxidative Stress

382

41.3.1.2 The Levels of TRX Proteins After ONT

383

41.3.1.3 The Levels of TRX Proteins After IOP Elevation

383

41.3.2 The Effect of TRX1 and TRX2 Overexpression on RGC Survival

383

41.3.2.1 TRX1 and TRX2 Overexpression Protects RGC-5 cells Against Oxidative Stress

383

41.3.2.2 TRX1 and TRX2 Overexpression Increases RGC Survival After ONT

384

41.3.2.3 TRX1 and TRX2 Overexpression Increases RGC Survival After IOP Elevation

384

41.4 Discussion

385

References

386

42 Near-Infrared Light Protect the Photoreceptor from Light-Induced Damage in Rats

388

42.1 Introduction

389

42.2 Material and Methods

390

42.2.1 Animal

390

42.2.2 Light Damage

390

42.2.3 670 nm LED Treatment

390

42.2.4 Evaluation of Photoreceptor Cell Function by Electroretinography

390

42.2.5 Morphological Evaluation of Photoreceptor Rescue by Quantitative Histology

391

42.2.6 Statistical Analysis

391

42.3 Results

391

42.3.1 LED Attenuated the Light Damage Area in Retinas

391

42.3.2 LED Protected the Morphology of Light Damage Retina

391

42.3.3 LED Protected the Function of Light Damage Retina

393

42.4 Discussions

394

References

396

43 BDNF Improves the Efficacy ERG Amplitude Maintenance by Transplantation of Retinal Stem Cells in RCS Rats

398

43.1 Introduction

398

43.2 Methods

399

43.2.1 Animals

399

43.2.2 Cell Preparation and Subretinal Transplantation

399

43.2.3 Flash-Electroretinogram (F-ERG) Recordings

400

43.2.4 Histology and Quantification

400

43.2.5 Data Analysis

401

43.3 Results

401

43.3.1 ERG Amplitudes and Latencies

401

43.3.2 ONL Thickness

402

43.3.3 Graft Cells Survival After Subretinal Transplantation

402

43.4 Discussion

402

References

406

44 The Role of Purinergic Receptors in Retinal Functionand Disease

408

44.1 Introduction

408

44.2 Mechanisms of ATP Release and Degradation

409

44.2.1 ATP Release

409

44.2.2 Degradation of ATP

409

44.3 Purinergic Signaling in the Retina

410

44.3.1 Purinergic Modulation of Neuronal Signaling

410

44.3.2 ATP and Glial Transmission

411

44.4 The Role of Purinergic Receptors in Retinal Disease

411

44.5 Concluding Remarks

412

References

412

Part IV Macular Degeneration

415

45 Fundus Autofluorescence Imaging in Age-Related Macular Degeneration and Geographic Atrophy

416

45.1 Background

416

45.2 Fundus Autofluorescence Overview

417

45.3 FAF Findings in Early AMD with Drusen Only

419

45.4 FAF Findings in Late AMD with Geographic Atrophy

419

45.5 Progression of Geographic Atrophy

420

45.6 Mechanisms of Progression

420

45.7 Research to Prevent Progression

421

45.8 Discussion

422

References

422

46 Endoplasmic Reticulum Stress as a Primary Pathogenic Mechanism Leading to Age-Related Macular Degeneration

424

46.1 Age Related Macular Degeneration Is a Leading Cause of Vision Loss

424

46.2 Oxidative Stress and Complement Activation are Common Pathways in End-Stage Disease

425

46.3 ER Stress and Oxidative Stress Interact

426

46.4 ER and Oxidative Stress as Triggers for Inflammation and Disease

426

46.5 Future Experimental Approaches

427

References

428

47 Proteomic and Genomic Biomarkers for Age-Related Macular Degeneration

431

47.1 Introduction

431

47.2 Methods

432

47.3 Results

433

47.3.1 CEP Adducts and Autoantibodies Are Elevated in AMD Plasma

433

47.3.2 AMD Risk Based on CEP Biomarkers and Genotype

433

47.3.3 The Association Between CEP Biomarkers and AMD Risk Genotypes

434

47.4 Discussion

436

References

436

48 Impaired Intracellular Signaling May AllowUp-Regulation of CTGF-Synthesis and Secondary Peri-Retinal Fibrosis in Human Retinal Pigment Epithelial Cells from Patients with Age-Related Macular Degeneration

438

48.1 Introduction

438

48.2 Methods

439

48.2.1 Chemicals

439

48.2.2 Establishment and Maintenance of hRPE Cell Cultures

440

48.2.3 Cellular Proliferation

440

48.2.4 Immunoprecipitation Assay

440

48.2.5 Statistical Analysis

441

48.3 Results

441

48.3.1 Effect of Glucose on 14C-CTGF Synthesis in hRPE Cells

441

48.3.2 Effect of IGF-1 on 14C-CTGF Synthesis in hRPE cells

441

48.3.3 Effect of PD98059 on Glucose Stimulated 14C-CTGF Synthesis in hRPE Cells

442

48.3.4 Effect of PD98059 on IGF-1 Stimulated 14C-CTGF Synthesis in hRPE Cells

442

48.4 Discussion

445

References

446

49 PPAR Nuclear Receptors and Altered RPE Lipid Metabolism in Age-Related Macular Degeneration

448

49.1 Introduction

448

49.1.1 Current Hypotheses Surrounding Sub-RPE Deposit Formation

449

49.1.2 Long Chain Poly-Unsaturated Fatty Acids (LCPUFA) are Associated with ARMD Risk

449

49.1.3 Peroxisome Proliferator Activated Receptors (PPARs) are Expressed in ARPE19 Cells

450

49.2 LcPUFA Regulates Gene Expression in ARPE19 Cells

451

49.2.1 Purpose and Methods

451

49.2.2 Results

451

49.2.3 Discussion

452

References

453

50 The Pathophysiology of Cigarette Smoking and Age-Related Macular Degeneration

456

50.1 Introduction

456

50.2 Cigarette Smoking as a Risk Factor for AMD

457

50.2.1 AMD and Cigarette Smoke

457

50.2.2 Cigarette Smoke Constituents

457

50.3 Oxidative Stress

457

50.3.1 Oxidative Damage in AMD

457

50.3.2 Reactive Oxygen Species in Cigarette Smoke

458

50.3.3 Acrolein-Induced Oxidative Stress

458

50.3.4 Cadmium-Induced Oxidative Stress

458

50.4 Cigarette Smoke Depletion of Antioxidant Protection

459

50.4.1 Systemic Antioxidant Mechanisms

459

50.4.2 Local Ocular Antioxidants

459

50.5 Non-oxidative Chemical Damage by Cigarette Smoke

460

50.5.1 Nicotine

460

50.5.2 Polycyclic Aromatic Hydrocarbons

460

50.6 Inflammation

460

50.6.1 Inflammation and AMD

460

50.6.2 Cigarette Smoke and Complement Pathway

461

50.6.3 Cigarette Smoke and Other Inflammatory Mediators

461

50.7 Vascular Changes

461

50.8 Conclusions

461

References

462

51 Oxidative Stress and the Ubiquitin Proteolytic System in Age-Related Macular Degeneration

466

51.1 Oxidative Stress and Age-Related Macular Degeneration

466

51.2 The Ubiquitin Proteolytic System (UPS) and Oxidative Stress in the Retina

467

51.3 The UPS and the Cytoprotective Transcription Factor, Nrf2

471

References

473

52 Slit-Robo Signaling in Ocular Angiogenesis

476

52.1 Ocular Angiogenesis

476

52.2 Slit-Robo Signaling in Axon Guidance

477

52.3 Slit-Robo Signaling in Angiogenesis

478

52.4 Slit-Robo Signaling in Ocular Angiogenesis

479

52.5 Signaling Pathway of Slit-Robo System in Angiogenesis

480

52.6 Perspective

481

References

481

Part V Animal Models of Retinal Degeneration

483

53 Evaluation of Retinal Degeneration in P27KIP1 Null Mouse

484

53.1 Introduction

485

53.2 Materials and Methods

485

53.2.1 Animals and Biosafety

485

53.2.2 MNU-Induced Retinal Degeneration

485

53.2.3 Electroretinography

485

53.2.4 Histological Examination and Immunohistochemistry

486

53.3 Results

486

53.3.1 Fundus Examination and Histology of the Retina

486

53.3.2 ERG

486

53.3.3 BrdU Incorporation

487

53.3.4 Immunohistology of Nestin

487

53.4 Discussion

487

References

488

54 Differences in Photoreceptor Sensitivity to Oxygen Stress Between Long Evans and Sprague-Dawley Rats

489

54.1 Introduction

489

54.2 Methods

490

54.2.1 Animal Strains and Oxygen Exposure

490

54.2.2 Electroretinography

490

54.2.3 Immunohistochemistry and TUNEL Labeling

491

54.3 Results

491

54.3.1 Rod and Cone Components of the ERG after Hyperoxia

491

54.3.2 Impact of Hyperoxia on the Rate of Photo receptor Death

491

54.3.3 Impact of Hyperoxia on GFAP Expression

491

54.4 Discussion

493

References

494

55 Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Thinking Beyond Cholesterol Deficiency

496

55.1 Introduction

496

55.2 The AY9944 Rat Model of SLOS: Biochemical Findings

498

55.3 Retinal Degeneration in the SLOS Rat Model: Histology and Ultrastructure

499

55.4 Retinal Degeneration in the SLOS Rat Model: Electrophysiological Deficits

501

55.5 Effects of Feeding a High-Cholesterol Diet

501

55.6 Perspective: Thinking Beyond the Cholesterol Deficiency in SLOS

502

References

503

56 Do Calcium Channel Blockers Rescue Dying Photoreceptors in the Pde6brd1 Mouse?

505

56.1 Introduction

505

56.1.1 The Pde6brd1 Mouse and Increased [cGMP]

506

56.1.2 Calcium Regulation and Overload in the Photoreceptor Inner Segment

507

56.2 D-cis-diltiazem and Neuroprotection in the Retina

508

56.2.1 Criticism of the Frasson Study

508

56.2.2 Subsequent Evidence Shows L-Type Channels Are Involved in Degeneration

509

56.3 Other Players May Be Involved

510

References

511

57 Effect of PBNA on the NO Content and NOS Activityin Ischemia/Reperfusion Injury in the Rat Retina

514

57.1 Introduction

515

57.2 Materials and Methods

515

57.2.1 Animals and Reagents

515

57.2.2 Induction of Retinal I/R

515

57.2.3 Detection of MDA and NO Concentration, SOD and GSH-PX Activity

516

57.2.4 Statistical Analysis

516

57.3 Results

516

57.3.1 Effect of PBNA on Serum NO Content in Retinal I/R Injury

516

57.3.2 Effect of PBNA on T-NOS Activity in Retinal I/R Injury

516

57.3.3 Effect of PBNA on iNOS Activity in Retinal I/R Injury

517

57.3.4 Effect of PBNA on Serum eNOS Activity in Retinal I/R Injury

518

57.4 Discussion

519

References

519

58 Recent Insights into the Mechanisms Underlying Light-Dependent Retinal Degeneration from X. Laevis Models of Retinitis Pigmentosa

521

References

526

59 A Hypoplastic Retinal Lamination in the Purpurin Knock Down Embryo in Zebrafish

528

59.1 Introduction

528

59.2 Materials and Methods

529

59.2.1 Experimental Animals

529

59.2.2 Screening of Genomic DNA for Zebrafish Purpurin

529

59.2.3 Construction of the pur-GFP Reporter Vector

530

59.2.4 Morpholino and Microinjections

530

59.2.5 In Situ Hybridization

530

59.2.6 RNA Isolation, RT-PCR and mRNA Synthesis

530

59.3 Results

531

59.3.1 Isolation and Characterization of Zebrafish Purpurin Gene

531

59.3.2 Similar Phenotypes of Purpurin and Crx Morphant

531

59.4 Rescuing Effect of Purpurin mRNA to the Crx Morphant

532

59.5 Discussion

533

References

534

60 Functional Changes in Inner Retinal Neurons in Animal Models of Photoreceptor Degeneration

536

60.1 Introduction

536

60.2 Bipolar Cell Function in Retinal Degeneration

537

60.2.1 Glutamate Receptors of Bipolar Cells in the Normal and Degenerating Retina

537

60.2.2 Evidence for Bipolar Cell Dysfunction

538

60.2.2.1 Rod Bipolar Cells

538

60.2.2.2 Cone Bipolar Cells

540

60.3 Ganglion Cell Function in Retinal Degeneration

540

References

542

61 Photoreceptor Cell Degeneration in Abcr--/-- Mice

544

61.1 Introduction

544

61.2 Methods

545

61.2.1 Animals and Rearing

545

61.2.2 Measurement of Outer Nuclear Layer Thickness

546

61.2.3 Counting Photoreceptor Nuclei

546

61.3 Results

546

61.4 Discussion

548

References

549

62 Investigating the Mechanism of Disease in the RP10 Form of Retinitis Pigmentosa

551

62.1 Introduction

551

62.2 Retinitis Pigmentosa

552

62.3 RP10 Disease Caused by Mutations in IMPDH1

552

62.4 IMPDH Structure and Function

553

62.5 IMPDH Binds Single Stranded Nucleic Acids

554

62.6 Retinal Isoforms of IMPDH1

554

62.7 Kinetic and Nucleic Acid Binding Properties of Retinal IMPDH1

556

62.8 Conclusion

556

References

557

63 Congenital Stationary Night Blindness in Mice A Tale of Two Cacna1f Mutants

559

63.1 Introduction

560

63.2 Methods

560

63.3 Results

561

63.4 Discussion

564

63.5 Conclusion

566

References

566

64 Protection of Photoreceptors in a Mouse Model of RP10

569

64.1 Introduction

569

64.2 Results

570

64.2.1 Evaluation of Optimal IMPDH1 Suppressors

570

64.2.2 RP10 Mouse Model

571

64.2.3 Rescue of Photoreceptor Cells by rAAV-Mediated Downregulation of Mutant IMPDH1

572

64.3 Discussion

573

References

574

65 Correlation Between Tissue Docosahexaenoic Acid Levels and Susceptibility to Light-Induced Retinal Degeneration

576

65.1 Introduction

576

65.2 Methods

577

65.3 Results

578

65.4 Discussion

580

References

581

66 Activation of Mller Cells Occurs During Retinal Degeneration in RCS Rats

583

66.1 Introduction

583

66.2 Materials and Methods

584

66.2.1 Animal

584

66.2.2 Immunohistochemical Staining

584

66.2.3 Western Blot Test

585

66.2.4 Müller Cell Cultures

585

66.2.5 Data Analysis

585

66.3 Results

586

66.3.1 Morphology and Quantity Changes of Müller Cells

586

66.3.2 Expression of GFAP and ERK in RCS Rat Müller Cells

586

66.3.3 Effect of Mixed Retinal Cells of RCS Rats on Normal Müller Cells

587

66.4 Discussion

587

References

590

67 Effect of 3-Daidzein Sulfonic Sodium on theAnti-oxidation of Retinal Ischemia/Reperfusion Injury in Rats

592

67.1 Introduction

593

67.2 Materials and Methods

593

67.2.1 Animals and Reagents

593

67.2.2 Induction of RI/R

593

67.2.3 Detection of MDA and NO Concentration, SOD and GSH-PX Activity

594

67.2.4 Statistical Analysis

594

67.3 Results

594

67.3.1 The Effect of DSS on the Concentration of MDA in Serum After RI/R Injury

594

67.3.2 The Effect of DSS on the Activity of SOD in Serum After RI/R Injury

595

67.3.3 The Effect of DSS on the Activity of Serum GSH-PX After RI/R Injury

595

67.3.4 The Effect of DSS on the Concentration of Serum NO After RI/R Injury

596

67.4 Discussion

597

References

597

68 Structural and Functional Phenotyping in theCone-Specific Photoreceptor Function Loss 1 (cpfl1) Mouse Mutant -- A Model of Cone Dystrophies

599

68.1 Introduction

600

68.2 Materials and Methods

600

68.2.1 Animals

600

68.2.2 Functional Testing

600

68.2.3 In Vivo Imaging

601

68.3 Results

601

68.3.1 Function

601

68.3.2 Morphology

603

68.4 Discussion

603

References

605

69 The Differential Role of Jak/Stat Signaling in Retinal Degeneration

606

69.1 Introduction

606

69.2 Materials and Methods

607

69.2.1 Mice and Light Exposure

607

69.2.2 Semi-Quantitative Real Time Polymerase Chain Reaction (PCR)

607

69.3 Results

608

69.3.1 STATs Are Induced Differently in Retinas of Light-Exposed and rd1 Mice

608

69.3.2 Shp-1 Is Induced After Light Exposure But Not in the rd1 Mouse

609

69.3.3 Jak3 mRNA Is Induced Similarly in the Model of Light Induced Photoreceptor Cell Death and the rd1 Mouse Model

609

69.4 Discussion

611

References

612

Part VI Neuroprotection and Gene Therapy

613

70 Gene Therapy in the Retinal Degeneration Slow Model of Retinitis Pigmentosa

614

70.1 Introduction

614

70.2 Diseases Associated with RDS Mutations

615

70.3 Current Animal Models

615

70.4 Gene Therapy in rds Models

616

70.5 Viral Gene Therapy Approaches

616

70.6 Non-viral Approaches

618

References

620

71 PEDF Promotes Retinal Neurosphere Formation and Expansion In Vitro

623

71.1 Introduction

623

71.2 Materials and Methods

625

71.2.1 Retinal Stem Cell Isolation and Culture

625

71.2.2 Single Sphere Passaging

625

71.2.3 Bromodeoxyuridine Labeling

625

71.2.4 Retinal Stem Cell Differentiation

626

71.2.5 Immunofluorescence

626

71.3 Results

626

71.3.1 PEDF Promotes Retinal Neurospheres Growth and Self-Renewal

626

71.3.2 Retinal Neurosphere Proliferation

628

71.3.3 Differentiation of Retinal Cells Precursors from RSCs

629

71.4 Discussion

630

References

631

72 A Multi-Stage Color Model Revisited: Implications for a Gene Therapy Cure for Red-Green Colorblindness

633

72.1 Introduction

633

72.2 A Brief History of Color Vision Theory

634

72.3 Color Vision from an Evolutionary Perspective

635

72.4 Evolutionary Constraints Lead to an Extension of Devalois Model

636

72.5 The Possibility of Gene Therapy to Cure Red-Green Colorblindness

639

References

640

73 Achromatopsia as a Potential Candidate for Gene Therapy

641

73.1 Human Achromatopsia

641

73.1.1 Clinical Manifestations

642

73.1.2 Current Achromatopsia Treatments

642

73.2 Genetics of Human Achromatopsia

642

73.2.1 GNAT2 Achromatopsia

643

73.2.2 CNG Achromatopsia

644

73.2.3 Achromatopsia Gene Therapy

644

73.3 The Mutant Gnat2 Mouse and Gene Therapy

644

73.3.1 The Cnga3 Mutant Mouse and Gene Therapy

645

73.3.2 The Cngb3 Mutant Dog and Gene Therapy

647

73.4 Prospects for Achromatopsia Gene Therapy

647

References

647

74 Function and Mechanism of CNTF/LIF Signalingin Retinogenesis

649

74.1 Introduction

649

74.2 Effects of CNTF/LIF on Photoreceptor and Bipolar Neuron Differentiation

650

74.3 Effects of CNTF/LIF on Muller Glia Genesis and Late Progenitor Proliferation

651

74.4 Effects of LIF Misexpression on Retinal Vasculature Development

651

74.5 Expression of CNTF/LIF Signaling Components in the Developing Retina

652

74.6 Signaling Events Triggered by CNTF/LIF During Retinogenesis

652

74.7 CNTF/LIF Regulate Numerous Genes Involved in Retinogenesis

653

74.8 Perspective

654

References

654

75 gp130 Activation in Muller Cells is Not Essentialfor Photoreceptor Protection from Light Damage

657

75.1 Introduction

657

75.2 Conditional gp130 Knockout in the Retinal Mller Cells

658

75.3 Effect of Impaired gp130 Activation in Mller Cells on LIF-Induced Photoreceptor Protection

659

75.4 Discussion

660

References

662

76 Neuroprotectin D1 Modulates the Induction of Pro-Inflammatory Signaling and Promotes Retinal Pigment Epithelial Cell Survival During Oxidative Stress

664

76.1 The Importance of RPE Cell Function and Integrity for Photoreceptor Survival

664

76.2 The Loss of RPE Cells in Retinal Degeneration

667

76.3 DHA and NPD1 Properties and Neuroprotection

668

76.4 NPD1 Modulates the Expression of Survival and Apoptotic-Related Proteins

669

References

669

77 Adeno-Associated Virus Serotype-9 Mediated Retinal Outer Plexiform Layer Transduction is Mainly Through the Photoreceptors

672

77.1 Introduction

673

77.2 AAV9-Mediated Gene Transfer in the Retina

673

77.3 The Sub-Cellular Location of AAV9 Transduction in the OPL

675

77.4 AAV9-Mediated Retinal Gene Transfer in mdx 3cv Mice

675

77.5 Subretinal Injection of AAV9 Vector Did Not Cause Acute Retinal Damage

677

77.6 Conclusions

677

References

677

Index

680